IMRA Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 feb 2023 @ 22:00):

IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin...

Stats
Dagens volum	271 721
Gjennomsnittsvolum	116 259
Markedsverdi	165.80M
EPS	$-0.000510 ( 2023-09-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	105.33
ATR14	$0.322 (5.09%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-29	Lyssikatos Joseph P	Sell	12 000	Stock Option (right to buy)
2023-12-29	Lyssikatos Joseph P	Buy	12 000	Common Stock
2023-12-29	Lyssikatos Joseph P	Sell	9 151	Common Stock
2023-12-29	Lyssikatos Joseph P	Sell	2 849	Common Stock
2023-12-28	Patel Anish	Sell	2 520	Common Stock

INSIDER POWER
82.98
Last 97 transactions
Buy: 15 631 291 \| Sell: 878 871

Volum Korrelasjon

Lang: -0.10 (neutral)

Kort: 0.82 (strong)

Signal:(75.335) Same movement expected

Imara Inc Korrelasjon

10 Mest positive korrelasjoner
BOCH	0.938
MMAC	0.916
SHSP	0.895
LMST	0.886
NETE	0.885
MNSB	0.859
SMCI	0.857
VOXX	0.844
WSC	0.841
STRL	0.84

10 Mest negative korrelasjoner
RMRM	-0.956
TDAC	-0.93
APOP	-0.923
GAINL	-0.91
AEY	-0.888
UK	-0.878
SVOK	-0.873
FANG	-0.865
BNRG	-0.862
HUSN	-0.861

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Imara Inc Korrelasjon - Valuta/Råvare

-0.18
( neutral )

-0.05
( neutral )

0.31
( neutral )

0.34
( neutral )

0.05
( neutral )

Imara Inc Økonomi

Annual	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$0.240

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$0.240

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-2.06

FY	2020
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-3.53

Financial Reports:

No articles found.

Imara Inc

IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.